poziotinib
poziotinib: sourced relationships with 2 companies · 3 clinical trials tracked.
poziotinib evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about poziotinib, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| Assertio Holdings, Inc. (ASRT) Under investigation for non-small cell lung cancer tumors wi… | Phase 2 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) | Phase 3 |
Clinical Trial Registry Records (3)
A Randomized, Phase 3 Study of Poziotinib in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring HER2 Exon 20 Mutations (PINNACLE)
Primary endpoint: Progression Free Survival (PFS)
A Phase 2 Study of Poziotinib in Patients With Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, With EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20)
Primary endpoint: Objective Response Rate (ORR)
A Phase II Study of Poziotinib in EGFR or HER2 Mutant Advanced Solid Tumors
Primary endpoint: Objective response rate a in patients with estimated glomerular filtration rate (EGFR) exon 20 mutant non-small Cell Lung Cancer (NSCLC) (Cohort 1)
Frequently asked questions
Which companies have sourced relationships with poziotinib?
poziotinib has dated SEC/FDA relationship records for Assertio Holdings, Inc., SPECTRUM PHARMACEUTICALS INC.
How many clinical trials involve poziotinib?
BioSniper tracks 3 clinical trials involving poziotinib.